Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Ísrael - hebreska - Ministry of Health

tec-o-pharm-libra ltd - chlormadinone acetate; ethinylestradiol - טבליות מצופות פילם - ethinylestradiol 0.03 mg; chlormadinone acetate 2 mg - etynodiol and estrogen - etynodiol and estrogen - oral hormonal contraceptive.

Ísrael - hebreska - Ministry of Health

merck sharp & dohme israel ltd - desogestrel; ethinylestradiol - טבליה - desogestrel 150 mcg; ethinylestradiol 30 mcg - desogestrel and estrogen - desogestrel and estrogen - oral contraceptive.

Ísrael - hebreska - Ministry of Health

bayer israel ltd - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - oral contraceptive.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.020 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.

Ísrael - hebreska - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - ethinylestradiol; gestodene - טבליות מצופות פילם - ethinylestradiol 0.015 mg; gestodene 0.06 mg - gestodene and estrogen - gestodene and estrogen - contraceptive.

Ísrael - hebreska - Ministry of Health

abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - gestodene 0.075 mg; ethinylestradiol 0.02 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.

Ísrael - hebreska - Ministry of Health

abic marketing ltd, israel - ethinylestradiol; gestodene - טבליות מצופות - ethinylestradiol 0.03 mg; gestodene 0.075 mg - gestodene and estrogen - gestodene and estrogen - oral contraception.

Ísrael - hebreska - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol - טבליות מצופות פילם - drospirenone 3 mg; ethinylestradiol 0.03 mg - drospirenone and estrogen - drospirenone and estrogen - oral contraception.

Ísrael - hebreska - Ministry of Health

bayer israel ltd - drospirenone; ethinylestradiol - טבליות מצופות פילם - drospirenone 3 mg; ethinylestradiol 0.02 mg - drospirenone and estrogen - drospirenone and estrogen - - oral contraception. - treatment of moderate acne vulgaris in women who seek oral contraception. - treatment of symptoms of premenstrual dysphoric disorder (pmdd ) in women who have chosen oral contraceptives as their method of birth control. the efficacy of yaz for pmdd was not assessed beyond 3 cycles. yaz has not been evaluated for treatment of pms ( premenstrual syndrome ).